Bacterial and fungal metabolites possessing anti-microbial activity against Xanthomonas species, compositions, methods, kits and uses relating to same

US11089785B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11089785-B2
Application numberUS-201616070703-A
CountryUS
Kind codeB2
Filing dateMay 20, 2016
Priority dateMay 22, 2015
Publication dateAug 17, 2021
Grant dateAug 17, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Anti-microbial metabolites secreted from various bacterial and/or fungal species are described that have anti-bacterial activity against Xanthomonas species, which cause disease in plant hosts, including a wide variety of crops. Bacterial and fungal species producing such metabolites were identified from environmental samples (seeds, different vegetable organs and soil) from different geographic locations. Compositions, methods, uses, and kits 5 relating to the identified anti-microbial metabolites are also described.

First claim

Opening claim text (preview).

The invention claimed is: 1. A biopesticide having antimicrobial activity against phytopathogenic Xanthomonas species, said biopesticide consisting of Bacillus amyloliquefaciens subsp. plantarum 71 (NRRL B-67021) and metabolites thereof, and one or more agriculturally acceptable excipients, wherein said metabolites comprise polyketide metabolites bacillaene, difficidin, and macrolactin. 2. The biopesticide of claim 1 , wherein said metabolites are extracellular bacterial metabolites. 3. The biopesticide of claim 1 , wherein said biopesticide has antimicrobial activity against Xanthomonas campestris, Xanthomonas perforans, Xanthomonas gardneri , or any combination thereof. 4. The biopesticide of claim 1 , wherein said antimicrobial activity comprises antagonistic activity. 5. The biopesticide of claim 1 , wherein said metabolites comprise lipopeptides and/or siderophores having anti- Xanthomonas activity. 6. The biopesticide of claim 5 , wherein said lipopeptides are non-ribosomal lipopeptides (NRPs). 7. The biopesticide of claim 5 , wherein said lipopeptides and/or siderophores comprise surfactin, fengycin, iturin, bacilysin, and bacillibactin, or any combination thereof. 8. The biopesticide of claim 1 , wherein said metabolites further comprise bacillaene, difficidin, macrolactin, kalimantacin/batumin, plantathiazolicin/plantazolicin, and bacteriocin, or any combination thereof. 9. The biopesticide of claim 1 , wherein the agriculturally acceptable excipient comprises a non-toxic carrier, surfactant, preservatives, nutrients, UV protectant, sticker, spreader, and/or chelating agent. 10. The biopesticide of claim 1 , wherein said composition is in the form of a liquid, concentrate, powder, tablet, gel, pellets, granules, or any combination thereof. 11. A method for controlling the growth of a pathogenic microorganism on a target plant or tissue, said method comprising contacting said target plant or tissue with the biopesticide of claim 1 . 12. A method for producing the biopesticide of claim 1 , the method comprising culturing viable cells of Bacillus amyloliquefaciens subsp. plantarum 71 (NRRL B-67021) under conditions enabling the production of said metabolites; harvesting and/or concentrating said metabolites produced from said viable cells; and formulating said metabolites to produce said biopesticide.

Assignees

Inventors

Classifications

  • A01N63/30Primary

    Microbial fungi; Substances produced thereby or obtained therefrom · CPC title

  • Animals; Substances produced thereby or obtained therefrom · CPC title

  • A01N63/25Primary

    Paenibacillus · CPC title

  • Bacillus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11089785B2 cover?
Anti-microbial metabolites secreted from various bacterial and/or fungal species are described that have anti-bacterial activity against Xanthomonas species, which cause disease in plant hosts, including a wide variety of crops. Bacterial and fungal species producing such metabolites were identified from environmental samples (seeds, different vegetable organs and soil) from different geograp…
Who is the assignee on this patent?
Inst Nat Rech Scient, Institut National De U Recherche Scient
What technology area does this patent fall under?
Primary CPC classification A01N63/30. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).